Expression and purification of human full-length N Oct-3, a transcription factor involved in melanoma growth

Protein Expression and Purification

Volumn 64, Issue 1, 2009, Pages 39-46

  Cabos Siguier, Béatrice ^a   Steunou, Anne Lise ^a   Joseph, Gérard ^a   Alazard, Robert ^a   Ducoux Petit, Manuelle ^a   Nieto, Laurence ^a   Monsarrat, Bernard ^a   Erard, Monique ^a   Clottes, Eric ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Circular dichro sm; EMSA; Fluorescence; Footprinting; POU proteins

Indexed keywords

COMPLEMENTARY DNA; DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; PEPTIDE FRAGMENT; TRANSCRIPTION FACTOR BRN 2; TRANSCRIPTION FACTOR BRN-2; TRANSCRIPTION FACTOR POU; TRYPSIN;

AMINO ACID SEQUENCE; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; CHEMISTRY; GENETICS; HUMAN; HYDROLYSIS; ISOLATION AND PURIFICATION; MELANOMA; METABOLISM; MOLECULAR GENETICS; MOLECULAR WEIGHT; PLASMID; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; BIOLOGICAL PROCESSES; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; HOMEODOMAIN PROTEINS; HUMANS; HYDROLYSIS; MELANOMA; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PLASMIDS; POU DOMAIN FACTORS; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; TRYPSIN;

EID: 57649103671     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.10.009     Document Type: Article

References (19)

1. Phillips K., and Luisi B. The virtuoso of versatility: POU proteins that flex to fit. J. Mol. Biol. 302 (2000) 1023-1039
2. Andersen B., and Rosenfeld M.G. POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocr. Rev. 22 (2001) 2-35
3. Alazard R., Blaud M., Elbaz S., Vossen C., Icre G., Joseph G., Nieto L., and Erard M. Identification of the 'NORE' (N-Oct-3 responsive element), a novel structural motif and composite element. Nucleic Acids Res. 33 (2005) 1513-1523
4. Schonemann M.D., Ryan A.K., McEvilly R.J., O'Connell S.M., Arias C.A., Kalla K.A., Li P., Sawchenko P.E., and Rosenfeld M.G. Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Dev. 9 (1995) 3122-3135
5. Nakai S., Kawano H., Yudate T., Nishi M., Kuno J., Nagata A., Jishage K., Hamada H., Fujii H., Kawamura K., Shiba K., and Noda T. The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse. Genes Dev. 9 (1995) 3109-3121
6. Hagino-Yamagishi K., Saijoh Y., Ikeda M., Ichikawa M., Minamikawa-Tachino R., and Hamada H. Predominant expression of Brn-2 in the postmitotic neurons of the developing mouse neocortex. Brain Res. 752 (1997) 261-268
7. Thomson J.A., Murphy K., Baker E., Sutherland G.R., Parsons P.G., Sturm R.A., and Thomson F. The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells. Oncogene 11 (1995) 691-700
8. Goodall J., Wellbrock C., Dexter T.J., Roberts K., Marais R., and Goding C.R. The Brn-2 transcription factor links activated BRAF to melanoma proliferation. Mol. Cell. Biol. 24 (2004) 2923-2931
9. Goodall J., Martinozzi S., Dexter T.J., Champeval D., Carreira S., Larue L., and Goding C.R. Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin. Mol. Cell. Biol. 24 (2004) 2915-2922
10. Wellbrock C., Rana S., Paterson H., Pickersgill H., Brummelkamp T., and Marais R. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS One 3 (2008) e2734
11. Millevoi S., Thion L., Joseph G., Vossen C., Ghisolfi-Nieto L., and Erard M. Atypical binding of the neuronal POU protein N-Oct3 to noncanonical DNA targets. Implications for heterodimerization with HNF-3 beta. Eur. J. Biochem. 268 (2001) 781-791
12. Blaud M., Vossen C., Joseph G., Alazard R., Erard M., and Nieto L. Characteristic patterns of N Oct-3 binding to a set of neuronal promoters. J. Mol. Biol. 339 (2004) 1049-1058
13. Nieto L., Joseph G., Stella A., Henri P., Schiltz O., Monsarrat B., Clottes E., and Erard M. Differential effects of phosphorylation on DNA binding properties of N Oct-3 are dictated by protein/DNA complex structures. J. Mol. Biol. 370 (2007) 687-700
14. Alazard R., Mourey L., Ebel C., Konarev P.V., Petoukhov M.V., Svergun D.I., and Erard M. Fine-tuning of intrinsic N-Oct-3 POU domain allostery by regulatory DNA targets. Nucleic Acids Res. 35 (2007) 4420-4432
15. Yamada S., Hata J., and Yamashita S. Molecular cloning of fish Pit-1 cDNA and its functional binding to promoter of gene expressed in the pituitary. J. Biol. Chem. 268 (1993) 24361-24366
16. Chiu C.C., John J.A., Hseu T.H., and Chang C.Y. Expression of ayu (Plecoglossus altivelis) Pit-1 in Escherichia coli: its purification and immunohistochemical detection using monoclonal antibody. Protein Expr. Purif. 24 (2002) 292-301
17. Ausubel F., Brent R., Kingston R., Mooore D., Seidman J., and Struhl K. Current Protocols in Molecular Biology (1993), John Wiley and Sons, Canada
18. Smit D.J., Smith A.G., Parsons P.G., Muscat G.E., and Sturm R.A. Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors. Eur. J. Biochem. 267 (2000) 6413-6422
19. Klemm J.D., Rould M.A., Aurora R., Herr W., and Pabo C.O. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 77 (1994) 21-32